Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis
Multiple Sclerosis (MS) is a highly disabling neurological disease characterized by inflammation, neuronal damage, and demyelination.Vision impairment is one of the major clinical features of MS.Previous studies from our lab have shown that MDL 72527, a pharmacological inhibitor of diamondbacks retro hat spermine oxidase (SMOX), is protective again